Sign in
Active, not recruitingNo phase

Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study

Key facts

Who runs it
Yale University
Where
New Haven, United StatesSee the site
Trial code
Status
Active, not recruiting
People taking part
80 people, planned
Started
20 Jul 2021
Expected to end
Apr 2027
Type of study
Observational, 2 groups
Treatments tested
  • 11C-UCB-J
Record updated
25 August 2026

Who can take part

Age
21 years to 60 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (10)Hide the full registry criteria

Who can take part

  • Age 21-60 years
  • Physically healthy by medical history, physical, neurological, ECG and laboratory examinations
  • For females, a negative serum pregnancy test
  • For CUD: DSM-5 criteria for Cocaine Use Disorder and positive urine toxicology showing recent use
  • For HC: Negative urine toxicology

Who cannot take part

  • Current use of psychotropic and/or potentially psychoactive prescription medications
  • DSM-5 criteria for other substance use disorders (e.g., alcohol, opiates, sedative hypnotics), except for nicotine
  • A primary DSM-5 Axis I major psychiatric disorder (e.g., schizophrenia, bipolar disorder, major depression, etc.) as determined by the Structured Clinical Interview for DSM-5 (SCID-5)
  • A history of significant and/or uncontrolled medical or neurological illness
  • Medical contraindications to MRI procedure

Where in United States

  • Connecticut Mental Health CenterNew Haven, United States

About the trial

What the trial wants to find out

The purpose of this research study is to measure synaptic density in the brain comparing individuals with cocaine use disorder to healthy controls.

The 2 groups in the trial

  • Cocaine Use Disorder

    Treatment: 11C-UCB-J

  • Healthy Control

    Treatment: 11C-UCB-J

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
25 August 2026